sulfadoxine has been researched along with Ocular Toxoplasmosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basiak, W; Borkowski, PK; Brydak-Godowska, J; Kajfasz, P; Olszyńska-Krowicka, M; Rabczenko, D; Świtaj, K; Żarnowska-Prymek, H | 1 |
Assouline, C; Ayoubi, JM; Berrébi, A; Bessières, MH; Cassaing, S; Lathière, M; Minville, V | 1 |
Bodaghi, B; Cassoux, N; Fardeau, C; Le Mer, Y; LeHoang, P; Lemaitre, C; Romand, S; Theaudin, M; Thulliez, P | 1 |
Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M | 1 |
Havlíková, M; Michalová, K; Ríhová, E | 1 |
Comte, P; Le Bras, M; Verin, P | 1 |
1 trial(s) available for sulfadoxine and Ocular Toxoplasmosis
Article | Year |
---|---|
[Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
Topics: Adolescent; Adult; Antimalarials; Child; Clinical Trials as Topic; Drug Combinations; Humans; Pyrimethamine; Recurrence; Sulfadoxine; Sulfanilamides; Time Factors; Toxoplasmosis, Ocular | 1989 |
5 other study(ies) available for sulfadoxine and Ocular Toxoplasmosis
Article | Year |
---|---|
The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Coccidiostats; Drug Administration Schedule; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Male; Medical Records; Middle Aged; Prednisone; Pyrimethamine; Recurrence; Secondary Prevention; Spiramycin; Sulfadoxine; Toxoplasmosis, Ocular; Treatment Outcome; Young Adult | 2016 |
Long-term outcome of children with congenital toxoplasmosis.
Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Risk Assessment; Spiramycin; Sulfadoxine; Time Factors; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular | 2010 |
[Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents; Antiprotozoal Agents; Azithromycin; Chorioretinitis; Clindamycin; Decision Trees; Diagnosis, Differential; Drug Combinations; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male; Middle Aged; Paracentesis; Polymerase Chain Reaction; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Ocular; Treatment Outcome | 2003 |
Ocular manifestations in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular; Vision Disorders | 2006 |
[Fansidar in the treatment of toxoplasmosis].
Topics: Adolescent; Adult; Antiprotozoal Agents; Drug Combinations; Humans; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Ocular | 1996 |